Renub Research

www.renub.com

USA Cardiovascular Devices Market Trends and Forecast (2010 2015)

Publisher: Renub Research Published: October, 2011

USA Cardiovascular Device - Market Overview

One in three American adults has some form of Cardiovascular Disease (CVD). Heart disease and stroke are the most common cardiovascular diseases. These are the first and third leading causes of death for both men and women in the United States. Cardiovascular Disease includes high blood pressure, coronary heart disease, heart failure and stroke. It is the leading cause of death in America and the World. United States cardiovascular devices market is expected to be over US$ 35 Billion by 2015, with a compound annual growth rate of approximately 7% from the period of 2011 to 2015. The cardiovascular device market is expected to be driven by increase in the incidence of cardiovascular diseases, an ageing population and greater adoption of technological advancements. The most rapidly growing segments in the cardiovascular device market are interventional cardiology, cardiac rhythm management, and cardiovascular prosthetic device market. Cardiac Rhythm Management devices market is one of the major contributing segments expected to generate more than US$ 16 Billion by 2015. Interventional cardiology devices represent one of the fastest developing areas in the overall cardiovascular device market which is expected to touch US$ 12 Billion by 2015. An increasing demand for minimally invasive surgeries amongst the rapidly aging population is expected to spark further growth in the cardiovascular devices market. Moreover, the cost efficiencies offered by lesser invasive methods expect to garner much favor amongst the healthcare payers in the coming years.

Report Details
USA Cardiovascular Devices Market Trends and Forecast (2010 2015) report published by Renub Research provides an in-depth analysis of the past, present and future prospects. The report has been researched at source globally and features latest available data covering:

Renub Research

Page 2 of 17

United States Cardiovascular Device Market (2006 - 2015) Top 6 cardiovascular device segment (Cardiac Rhythm Management, Interventional Cardiology , Cardiovascular Surgery, Cardiovascular Prosthetic, Peripheral Vascular & Cardiovascular Monitoring & Diagnostic Device) market data from 2006 to 2015

Top 12 cardiovascular devices (Implantable Cardioverter Defibrillator, Pacemaker, Cardiac Resynchronization Therapy-Pacemaker, Angioplasty, Angiography, PTCA Baloon, Coronary Stent, Anastomosis, Endoscopic Vessel Harvesting, Ventricular Assist Device, Heart Valve, Prothetic Heart Valve) market data from 2006 to 2015

Mergers and Acquisitions in the Cardiovascular Device market Key drivers of growth in the Cardiovascular Device market Key Companies analysis in the Cardiovascular Device market

Research Highlights
More than 81 Million people are estimated to be suffering from CVD in the US United States cardiovascular device market is expected to over US$ 35 Billion by 2015 Cardiac Rhythm Management devices market is one of the major contributing segments which is expected to generate more than US$ 16 Billion by 2015 Interventional cardiology devices represent one of the fastest growing segment in the overall cardiovascular device market Coronary stent is the fastest growing categories in the interventional cardiology market it registered a rapid growth due to rapid advancements in the area of drugeluting Coronary Stent M&A activity of cardiovascular device companies is a significant of US$ 31 Billion deals in 2006

Key Companies Analyzed

This section covers the key facts about the major companies that play an important role in United States Cardiovascular Market. The key companies analyzed in this section are Sorin Group, Medtronic, St. Edwards Life Science and St. Jude Medical. All the companies have
Renub Research Page 3 of 17

been analyzed from three points 1) Revenue of the company from cardiovascular device segment globally 2) Strength of the company in cardiovascular device segment 3) Weakness of the company in cardiovascular device segment.

Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts. Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

Renub Research

Page 4 of 17

About Us
Renub Research
in international is a leading Market Research and Information Analysis Company with Researches, Surveys, Business and Consulting.

centers at Noida India and Roswell USA. We have more than 7 years of experience especially Business-to-Business Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others. Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in todays ultra-competitive markets.

For more information on us or to view any of our sample work you can mail us at [email protected]

Renub Research

Page 5 of 17

Published By

Renub Research
A116B, Sector27 Noida 201301 Phone: +91-120-421-9822, 254-5750 (India) +1-678-302-0700 (USA) Fax : +91-120-424-9780 Email: [email protected] www.renub.com

USA Cardiovascular Devices Market Trends and Forecast (2010 2015) Renub Research, 2011 Edition 1.0 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic mechanical, photocopying, recording or otherwise without the prior written permission of the publisher

Renub Research

Page 6 of 17

Table of Contents
1. 2. 3. Executive Summary United States Cardiovascular Device Market & Forecast (2006 2015) United States Cardiovascular Device Market & Forecast (2006 2015) 3.1 Cardiac Rhythm Management Implantable Cardioverter Defibrillator Pacemaker Cardiac Resynchronization Therapy-Pacemaker (CRT-P)

3.1.1 3.1.2 3.1.3 3.2

Interventional Cardiology Angioplasty Angiography PTCA Balloon Coronary Stent

3.2.1 3.2.2 3.2.3 3.2.4 3.3

Cardiovascular Surgery Anastomosis Device Endoscopic Vessel Harvesting Device Ventricular Assist Device (VAD) Heart Valve

3.3.1 3.3.2 3.3.3 3.3.4 3.4

Cardiovascular Prosthetic Device Prosthetic Heart Valve

3.4.1 3.5 3.6 4.

Peripheral Vascular Device Cardiovascular Monitoring & Diagnostic Device

Growth Drivers in Cardiovascular Device Market 4.1 4.2 4.3 4.4 Aging of the Population Obesity Smoking High Incidence of Cardiovascular Death

5.

Challenges 5.1 5.2 Significance of Cardiovascular Device Innovation Regulation

Renub Research

Page 7 of 17

6. 7.

Merger & Acquisition in Cardiovascular Device Market Key Companies 7.1 Sorin Globally - Sorin Revenue from Cardiovascular Devices Strength Weaknesses

7.1.1 7.1.2 7.1.3 7.2

Edwards Lifesciences Global - St. Edwards Revenue from Cardiovascular Devices United States - St. Edwards Revenue from Cardiovascular Devices Strength Weaknesses

7.2.1 7.2.2 7.2.3 7.2.4 7.3

St. Jude Medical Globally - St. Jude Revenue from Medical Cardiovascular Devices Strength Weaknesses

7.3.1 7.3.2 7.3.3 7.4

Medtronic Globally Medtronic Revenue from Cardiovascular Devices Strength Weaknesses

7.4.1 7.4.2 7.4.3

Renub Research

Page 8 of 17

List of Figures:
Figure 2-1: United States Cardiovascular Device Market (Million US$), 2006 2010 Figure 2-2: United States Forecast for Cardiovascular Device Market (Million US$), 2011 2015 Figure 3-1: United States Cardiac Rhythm Management Market (Million US$), 2006 2010 Figure 3-2: United States Forecast for Cardiac Rhythm Management Market (Million US$), 2011 2015 Figure 3-3: United States Implantable Cardioverter Defibrillator Market (Million US$), 2003 2010 Figure 3-4: United States Forecast for Implantable Cardioverter Defibrillator Market (Million US$), 2011 2015 Figure 3-5: United States Pacemaker Market (Million US$), 2003 2010 Figure 3-6: United States Forecast for Pacemaker Market (Million US$), 2011 2015 Figure 3-7: United States CRT-P Market (Million US$), 2005 2010 Figure 3-8: United States Forecast for CRT-P Market (Million US$), 2011 2015 Figure 3-9: United States Interventional Cardiology Market (Million US$), 2006 2010 Figure 3-10: United States Forecast for Interventional Cardiology Market (Million US$), 2011 2015 Figure 3-11: United States Angioplasty Market (Million US$), 2003 2010 Figure 3-12: United States Forecast for Angioplasty Market (Million US$), 2011 2015 Figure 3-13: United States Angiography Market (Million US$), 2003 2010 Figure 3-14: United States Forecast for Angiography Market (Million US$), 2011 2015 Figure 3-15: United States PTCA Balloon Market (Million US$), 2003 2010 Figure 3-16: United States Forecast for PTCA Balloon Market (Million US$), 2011 2015 Figure 3-17: United States Coronary Stent Market (Million US$), 2003 2010 Figure 3-18: United States Forecast for Coronary Stent Market (Million US$), 2011 2015 Figure 3-19: United States Cardiovascular Surgery Market (Million US$), 2006 2010 Figure 3-20: United States Forecast for Cardiovascular Surgery Market (Million US$), 2011 2015 Figure 3-21: United States Forecast for Anastomosis Device Market (Million US$), 2011 2015 Figure 3-22: United States Endoscopic Vessel Harvesting Market (Million US$), 2003 2010 Figure 3-23: United States Forecast for Endoscopic Vessel Harvesting Market (Million US$), 2011 2015 Figure 3-24: United States Ventricular Assist Device Market (Million US$), 2004 2010 Figure 3-25: United States Forecast for Ventricular Assist Device Market (Million US$), 2011 2015 Figure 3-26: United States Heart Valve Market (Million US$), 2004 2010 Figure 3-27: United States Forecast for Heart Valve Market (Million US$), 2011 2015 Figure 3-28: United States Cardiovascular Prosthetic Market (Million US$), 2006 2010 Figure 3-29: United States Forecast for Cardiovascular Prosthetic Market (Million US$), 2011 2015 Figure 3-30: United States Prosthetic Heart Valve Market (Million US$), 2008 2010 Figure 3-31: United States Forecast for Prosthetic Heart Valve Market (Million US$), 2011 2015

Renub Research

Page 9 of 17

Figure 3-32: United States Peripheral Vascular Market (Million US$), 2006 2010 Figure 3-33: United States Forecast for Peripheral Vascular Market (Million US$), 2011 2015 Figure 3-34: United States Cardiovascular Monitoring & Diagnostic Market (Million US$), 2006 2010 Figure 3-35: United States Forecast for Cardiovascular Monitoring & Diagnostic Market (Million US$), 2011 2015 Figure 4-1: Population Aged 60 or over: World & Development Regions, 1950 2050 Figure 4-2: Old-age Dependency Ratio: Major Areas, 2009 & 2050 Figure 7-1: Global Sorin Cardiovascular Devices Revenue (Million US$), 2008 2010 Figure 7-2: Global St Edwards Cardiovascular Devices Revenue (Million US$), 2008 2010 Figure 7-3: United States St Edwards Cardiovascular Devices Revenue (Million US$), 2008 2010 Figure 7-4: Global St Jude Medical Cardiovascular Devices Revenue (Million US$), 2007 2010 Figure 7-5: Global Medtronic Cardiovascular Devices Revenue (Million US$), 2007 2010

Renub Research

Page 10 of 17

List of Tables:
Table 4-1: Global Population aged 60 or over, 65 or over and 80 or over by Sex (Thousands) Table 4-2: Worldwide Prevalence of Adult Obesity for Developed Countries (Percent %), 2002 2005 Table 4-3: Worldwide Prevalence of Adult Obesity for Developing Countries (Percent %), 1998 2005 Table 4-4: United States Deaths from Cardiovascular Diseases (Thousand), 1900 2007 Table 4-5: United States Forecast for Crude Prevalence (Percent), 2010, 2015, 2020, 2025, 2030 Table 4-6: United States Forecast for Direct (Medical) costs (Billion US$), 2010, 2015, 2020, 2025, 2030 Table 4-7: United States Forecast for Indirect (lost productivity) costs (Billion US$), 2010, 2015 2020, 2025, 2030 Table 6-1: Worldwide Merger & Acquisition (Million US$), 1998 2010

Renub Research

Page 11 of 17

Order Form
Scan and e-mail this page to [email protected], alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to [email protected]

Format
Report Title: USA Cardiovascular Devices Market Trends and Forecast (2010 2015)

Single User (Email from Publisher) US$ 975

Hard Copy (Mail Delivery) US$ 1,075

CD Rom (Mail Delivery) US$ 1,075

Global Site License (Multiple User License) US$ 1,500

For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.): http://renub.com/reports/showdetails.aspx?id=50 2) Order by Wire Transfer: http://renub.com/reports/wiretransfer.aspx?id=50&pid=1178 To pay by Wire Transfer, please, fill in your contact details in the form below:

Renub Research

Page 12 of 17

Bank Details
Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi 110001 India

Contact Information
First Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message: Last Name:

Renub Research

Page 13 of 17

3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research A -116B Sector -27 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at [email protected] or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research Twitter: http://twitter.com/RenubResearch

Renub Research

Page 14 of 17

Related Reports
Global Osteoporosis Market & Drugs Analysis 2010 2015 Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 2015) Global Molecular Diagnostics Market & Future Forecast 2010 - 2014 Alzheimers Disease Patients & Market Worldwide, Future Scenario (2010 2015) & Drugs Analysis Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 - 2014) Personalized Medicine Market (2010 - 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 2014) Glucose Monitoring Devices Market Worldwide (2010 2014) Global Diabetes Market Trends & Future Forecast Diabetes Drug (Anti-Diabetic Drug), Insulin, DPP-IV, GLP-1 Asia Medical Tourism Analysis (2008 2013) Global Molecular Diagnostics Market: Opportunities & Future Forecast Insulin Delivery Devices Market Analysis and Future Forecast World Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments

Renub Research

Page 15 of 17

Our Partial List of Clients

Redbus Becton Dickinson Pfizer Intercell Sanofi Pasteur Stanford Burgess Pequot Capital DMI Transgene S.A. Ixia communications Toyota Tsusho Amercia Inc. National Health Research Institutes Abbott Diabetes Care Corning Incorporated - Life Sciences L.E.K. Consulting GmbH Syntiron MediVas LLC Credit Suisse Dune Medical QIAGEN Inje University Mapp Biopharmaceutical Institute for Information Industry NorDiag ASA Renub Research Rep e Inv Medicas SA de Innogenetics Page 16 of 17

Bain WAKE Technology Services, Inc. PSS World Medical Relypsa C&K components Konkuk University Resonetics Samsung SEKISUI MEDICAL CO. LTD. Plentyoffish Media INC Arthur D Little Gmbh Morgan Stanley Takeda Pharmaceutical Corporation Hokkai School of Commerce Ministry of Manpower Singapore GenOmind, LLC. Goldman Sachs & Co NTT Advanced Technology Tokyo Womens Medical University The Chemo-Sero-Therapeutic Research Trade Council of Iceland Jpmorgan, Ets Trading GE Healthcare IT ixia communications

Disclaimer
This research report is published by Renub Research. All rights reserved. Reproduction or redistribution of this research report in any form for any business purpose is expressly prohibited without written permission of www.renub.com and any payments of a specified fee. Requests to republish any material may be sent to us at [email protected]. Most of the information available in this report is within the public domain. The submitting authors or other copyright holders retain rights for reproduction or redistribution. All persons reproducing or redistributing this information are expected to adhere to the terms and constraints invoked by the copyright holder. Such protected material, however, may be used under the terms of "fair use as defined in the copyright laws, which generally permit use for non-commercial educational purposes such as teaching, research, criticism, and news reporting. With respect to documents available, neither the company nor any of its employees makes any warranty, express or implied, including the warranties of merchantability and fitness for a particular purpose, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights.

Renub Research

Page 17 of 17